352445 <common-name>3-(benzylamino)-1-[12-[3-(benzylamino)propanoyl]-3,12-diaza-6,9-diazoniadispiro[5.2.59.26]hexadecan-3-yl]propan-1-one</common-name> <description>3-(benzylamino)-1-[12-[3-(benzylamino)propanoyl]-3,12-diaza-6,9-diazoniadispiro[5.2.59.26]hexadecan-3-yl]propan-1-one has the chemical formula C32H48N6O2+2. With an average molecular weight of 548.80 g/mol, 3-(benzylamino)-1-[12-[3-(benzylamino)propanoyl]-3,12-diaza-6,9-diazoniadispiro[5.2.59.26]hexadecan-3-yl]propan-1-one is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>13397724</pubchem-id> <chemical-formula>C32H48N6O2+2</chemical-formula> <weight>548.8</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T18:46:51Z</created-at> <updated-at type="dateTime">2026-08-31T18:46:51Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1C[N+]2(CCN1C(=O)CCNCC3=CC=CC=C3)CC[N+]4(CCN(CC4)C(=O)CCNCC5=CC=CC=C5)CC2</moldb-smiles> <moldb-formula>C32H48N6O2+2</moldb-formula> <moldb-inchi>InChI=1S/C32H48N6O2/c39-31(11-13-33-27-29-7-3-1-4-8-29)35-15-19-37(20-16-35)23-25-38(26-24-37)21-17-36(18-22-38)32(40)12-14-34-28-30-9-5-2-6-10-30/h1-10,33-34H,11-28H2/q+2</moldb-inchi> <moldb-inchikey>IYDASUZKERIVJU-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">548.3838748</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>0.6</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM348338</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>3-(benzylamino)-1-[12-[3-(benzylamino)propanoyl]-3,12-diaza-6,9-diazoniadispiro[5.2.59.26]hexadecan-3-yl]propan-1-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0302733</sync-id> <structure-inchikey>IYDASUZKERIVJU-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>80001000000000000000000000000000000000000001000000000000000000000020000000000400000000200000000000000000000000010000000000000000000040000002002000100000000000000000000000800000000001000000000000000000000000000002010000000000000008084000000000000020000080000000000000008000000000810000000000000000000000000000000000000000000008000800000000000000000000a000000000000000001008000000010000000000000000000000000000000000000220000000000000000000000000000040000000000400000000000000000200004000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAoAAAALAAAAIABBgBgAAAAAgIGAGAAAAAC AgcgIgAAAAEEBgBgAAAAAgIGAGAAAAACAgcAKAAAAAMDBgAoAAAAAwQIACgA AAADAgYAYAAAAAICBgBgAAAAAgIHAGAAAAACAQYAYAAAAAICBkAoAAAAAwQG QGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEG AGAAAAACAgYAYAAAAAICByAiAAAAAQQGAGAAAAACAgYAYAAAAAICBwAoAAAA AwMGAGAAAAACAgYAYAAAAAICBgAoAAAAAwQIACgAAAADAgYAYAAAAAICBgBg AAAAAgIHAGAAAAACAQYAYAAAAAICBkAoAAAAAwQGQGgAAAADAwEGQGgAAAAD AwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGAGAAAAACAgYAYAAAAAIC CwABAAECAAIDAAMEAAQFAAUGIAYHKAIGCAAICQAJCgAKCwALDAAMDWgMDQ5o DA4PaAwPEGgMEBFoDAISABITABMUABQVABUWABYXABcYABgZABcaIBobKAIa HAAcHQAdHgAeHwAfIAAgIWgMISJoDCIjaAwjJGgMJCVoDBQmACYnAAUAACcC ABEMaAwZFAAlIGgMQgUAAAAGAAUEAwIBBg0ODxARDAYSExQmJwIGFRYXGBkU BiEiIyQlIBcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:50:12Z</structure-indexed-at> </compound>